Lori N. Sikorra, FNP

Lori Sikorra practices at County of Ventura in Oxnard, California.

Lori Sikorra's NPI, 1316428345, was assigned on August 27, 2018. Lori Sikorra holds California license 95009830.

Lori Sikorra's primary practice is County of Ventura, at 2901 N Ventura Rd, Oxnard, CA 93036 in Ventura County. The practice phone is (805) 677-5223.

Lori Sikorra's primary practice is County of Ventura in Oxnard, California. Lori Sikorra is also affiliated with Dignity Health - St. John's Regional Medical Center. The medical group on file is Mercy Medical Group. Dmand AI also links Lori Sikorra to 1 more group practice or clinic, named with a free account. Lori Sikorra's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Lori Sikorra practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Lori Sikorra's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Lori Sikorra is licensed in California.

Dmand AI lists acute skin infection, ADHD, alzheimer's disease, ankle or foot injury, asthma, chronic diabetes, chronic kidney disease and chronic obstructive pulmonary disease (COPD) among the conditions Lori Sikorra treats.

CMS data shows 618 Medicare services from Lori Sikorra across 8 procedure codes in 2024, for 348 Medicare patients. Medicare paid $48,257 for them. Every service was in an office.

CMS counts 348 Medicare patients who saw Lori Sikorra in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lori Sikorra's median patient age at 76, with 48% women.

In 2024, Lori Sikorra wrote 1,597 Medicare Part D claims for 323 patients. 84% of them were for generic drugs. CMS names the drug for 1,083 of them, across 42 drugs with 11 or more claims each, at $85,857 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Lori Sikorra for performance year 2024, reported through an alternative payment model (APM). Lori Sikorra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lori Sikorra as offering telehealth.

CMS Open Payments shows 71 general payments to Lori Sikorra from 19 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $288.